Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • LIGAND PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY FY FY FY FY
    Assets
    Cash and Short Term Investments — — — — —
    Net Receivables — — — — —
    Total Inventories — — — — —
    Progress Payments & Others — — — — —
    Prepaid Expenses — — — — —
    Other Current Assets — — — — —
    Current Assets Total — — — — —
    Long Term Receivables — — — — —
    Investment in Unconsolidated Subsidiaries — — — — —
    Other Investments — — — — —
    Property, Plant & Equipment Net — — — — —
    Property, Plant & Equipment Gross — — — — —
    Accumulated Depreciation — — — — —
    Other Assets — — — — —
    Deferred Charges — — — — —
    Tangible Other Assets — — — — —
    Intangible Other Assets — — — — —
    Total Assets — — — — —
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt — — — — —
    Accrued Payroll — — — — —
    Income Taxes Payable — — — — —
    Dividends Payable — — — — —
    Other Current Liabilities — — — — —
    Current Liabilities Total — — — — —
    Long Term Debt — — — — —
    Provision for Risks & Charges — — — — —
    Deferred Taxes — — — — —
    Deferred Income — — — — —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities — — — — —
    Total Liabilities — — — — —
    Shareholders Equity
    Non-Equity Reserves — — — — —
    Minority Interest — — — — —
    Preferred Stock — — — — —
    Common Equity — — — — —
    Common Stock — — — — —
    Capital Surplus — — — — —
    Revaluation Reserves — — — — —
    Other Appropriated Reserves — — — — —
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings — — — — —
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees — — — — —
    Unrealized Foreign Exchange Gain (Loss) — — — — —
    Unrealized Gain (Loss) on Marketable Securities — — — — —
    Treasury Stock — — — — —
    Total Liabilities & Shareholders Equity — — — — —
    Common Shares Outstanding — — — — —